FDA Inspection 1068351 — MetaGen Corp.
The FDA completed an inspection of MetaGen Corp. on Sep 11, 2018 in Old Saybrook, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Old Saybrook, CT (United States)